PMA
P040044: MATRIX VASCULAR CLOSURE SYSTEM (VSG)
FDA PMA · Device, hemostasis, vascular · Cordis US Corporation
Key facts
| PMA number | P040044 |
|---|---|
| Trade name | MATRIX VASCULAR CLOSURE SYSTEM (VSG) |
| Generic name | Device, hemostasis, vascular |
| Applicant | Cordis US Corporation |
| Owner/operator | Cordis US Corp. |
| Product code | MGB |
| Approval date | Aug 17, 2005 |
| Docket number | 05M-0359 |
| Notice date | Sep 8, 2005 |
| Establishment registration | 1016427 |
| FEI number | 1016427 |
At a glance
- 100–999 Supplements
- May 14, 2026 Latest supplement decision
- No Withdrawn
- Yes Summary of safety and effectiveness on file
- 1–9 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: